Diode Laser Ablation for Bladder Cancer
Author Information
Author(s): I. A. Khalil, Younes Nagy, Badawi Alaeddin, Al Rumaihi Khalid
Primary Institution: Hamad Medical Corporation, Doha, Qatar
Hypothesis
This study aims to assess the efficacy and safety of office-based diode laser ablation for treating recurrent low-grade non-muscle-invasive bladder cancer under local anesthesia.
Conclusion
Office-based diode laser ablation is a safe, effective, and well-tolerated alternative for treating recurrent low-grade NMIBC with a low volume, less than 1 cm, under local anesthesia.
Supporting Evidence
- The recurrence rate post-ablation for the entire cohort was 70%.
- Patients tolerated the procedure well, reporting only mild pain.
- There were no complications greater than grade 1 on the Clavien-Dindo classification.
Takeaway
Doctors can use a special laser to treat bladder cancer in a way that is safe and doesn't hurt too much, helping patients avoid more serious surgeries.
Methodology
A retrospective analysis was conducted on patients with recurrent low-grade NMIBC who underwent office-based diode transurethral laser ablation under local anesthesia.
Limitations
The study is retrospective with a small sample size.
Participant Demographics
Mean age of participants was 55 years, with a male-to-female ratio of 3.2:1.
Statistical Information
P-Value
0.046
Statistical Significance
p=0.046
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website